EUVIMEDEUVIMED entdecken
Open Access

High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis

Xinkui Xiong, Lei Zhang, Bao Zang, Dafu Xu, Chen Chen, Gaochao Dong, Wenjie Xia, Yanhu Wu

Oncology Reports · 2023

DOI: 10.3892/or.2023.8532 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Xinkui Xiong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaiyin, Huaian, Jiangsu 223001, P.R. Ch…. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Lung Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

According to the diverse cellular morphology, lung adenocarcinoma (LUAD) was classified into five pathological subtypes, referred to as follows: High‑risk group (micropapillary and solid), intermediate‑risk group (acinar and papillary) and low‑risk group (epidic). Nevertheless, little is known about the biological function of long non‑coding RNA (lncRNA) in the molecular determination of LUAD histologic patterns. Screening the transcriptional expression data from TCGA‑LUAD, the differentially expressed lncRNA across the divergent pathological subtypes were explored. Pan‑cancer analysis revealed the characteristic of FAM83A‑AS1, which was also confirmed in the LUAD tissues. The function of FAM83A‑AS1 was uncovered through the in vitro assays. RNA immunoprecipitation and dual‑luciferase reporter assays were performed to explore the molecular mechanisms of FAM83A‑AS1. In the present study, it was identified that the expression of FAM83A‑AS1 was increased from the low‑risk group to the high, which was associated with a poorer prognosis and higher risk of recurrence. Pan‑cancer analysis revealed that FAM83A‑AS1 was positively correlated with high tumor mutational burden. Additionally, FAM83A‑AS1 promoted cell migration, invasion and growth of LUAD cancer cells. Mechanistically, FAM83A‑AS1 sponged miR‑202‑3p to regulate the expression of hexokinase II (HK2) in post‑transcription, which facilitated the malignancy and glycolysis. The present study uncovered the biological roles of FAM83A‑AS1/miR‑202‑3p/HK2 axis in regulating malignancy and glycolysis of LUAD, which provided novel avenues to addressing the determination of histologic patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingLung NeoplasmsAdenocarcinomaHumansHexokinaseLungGlycolysisCell ProliferationGene Expression Regulation, NeoplasticNeoplasm Proteins

Stichwörter der Autor:innen

FAM83A‑AS1glycolysishexokinase IIhistological pathology subtypelung adenocarcinoma

Substanzen

MicroRNAsHexokinaseRNA, Long NoncodingFAM83A protein, humanNeoplasm ProteinsMIRN202 microRNA, human

Autor:innen und Institutionen

  • Department of Thoracic Surgery, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huaiyin, Huaian, Jiangsu 223001, P.R. China.
  • Department of Medical Oncology, Xuzhou Central Hospital, Quanshan, Xuzhou 221000, P.R. China.
  • Department of Thoracic Surgery, Nanjing Medical University Affiliated Cancer Hospital & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu 210000, P.R. China.
  • Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210000, P.R. China.

Zitieren

APA

Xiong, X., Zhang, L., Zang, B., Xu, D., Chen, C., Dong, G., Xia, W., & Wu, Y. (2023). High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis. Oncology Reports. https://doi.org/10.3892/or.2023.8532

Vancouver

Xiong X, Zhang L, Zang B, Xu D, Chen C, Dong G, et al. High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis. Oncology Reports. 2023. doi:10.3892/or.2023.8532

BibTeX
@article{Xiong2023,
  author = {Xiong, Xinkui and Zhang, Lei and Zang, Bao and Xu, Dafu and Chen, Chen and Dong, Gaochao and Xia, Wenjie and Wu, Yanhu},
  title = {High‑risk pathological subtype associated FAM83A‑AS1 promotes malignancy and glycolysis of lung adenocarcinoma via miR‑202‑3p/HK2 axis},
  journal = {Oncology Reports},
  year = {2023},
  doi = {10.3892/or.2023.8532}
}
Kostenlos starten →